We conducted a health economic evaluation of the KiVa anti-bullying programme, alongside the Stand Together trial, to explore its cost-effectiveness for reducing bullying amongst 7-to-11-year-olds in UK primary schools.

Our presentation will outline the importance of health economics in contributing to the evidence-base for the KiVa programme and will introduce our approach and methods for costing and evaluating KiVa compared to usual practice.

Cost calculations were conducted from an education-sector perspective and included KiVa training and resources plus staff-time preparing and delivering lessons. The estimated costs of KiVa and usual practice will be used in three separate health economic analyses to explore cost-effectiveness;
i) a cost-utility analysis exploring the incremental cost of KiVa per incremental pupil-reported quality-adjusted life year (QALY) gained,
ii) a cost-effectiveness analysis exploring the incremental cost per incremental bullying incident avoided (BIA),
iii) a cost-consequence analysis comparing costs with a wide range of pupil- and teacher outcomes.